Bruker Corporation Announces Closing of the Acquisition of the Bruker BioSpin Group
The former Bruker BioSciences Corporation, presently being renamed Bruker Corporation, announced that today it has closed the previously-announced acquisition of the Bruker BioSpin Group. Approximately 57.5 million new unregistered shares of BRKR common stock were issued for the stock component of the acquisition consideration. At the closing price per share of $10.86 on February 25, 2008, the stock portion of the aggregate consideration for the acquisition was approximately $624.9 million.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.